Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway

Fig. 1

TG2 is overexpressed in breast cancer tissues and correlated with poor survival. The representative images of immunochemistry staining of breast cancer tissues for negative (normal tissues, A, B), weak (1+, C, D), mild (2+, E, F) and strong (3+, G, H) TG2 expression. The lower panel represents the magnification (× 200) of squared area from the upper panel (× 80). I the mRNA expression of TG2 was performed in 40 paired adjacent and tumor samples by RT-qPCR. J High expression of TG2 is correlated with poor overall survival in Kaplan-Meier analysis. (* p<0.05)

Back to article page